1. Definitions and incidence of cardiac syndrome X: review and analysis of clinical data

   • I. A. C. Vermeltfoort
   • P. G. H. M. Raijmakers
   • G. J. J. Teule

   Review Open access 21 April 2010 Pages: 475 - 481

   

2. Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis

   • Derliz Mereles
   • Sebastian J. Buss
   • Hugo A. Katus

   Original Paper 10 March 2010 Pages: 483 - 490

   

3. Strain and strain rate echocardiography for evaluation of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension

   • Arthur Filusch
   • Derliz Mereles
   • F. Joachim Meyer

   Original Paper 30 March 2010 Pages: 491 - 498

   

4. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence

   • Jan Börgel
   • Stephanie Springer
   • Andreas Mügge

   Original Paper 02 April 2010 Pages: 499 - 506

5. Incidence and predictors of atrial fibrillation following transcatheter closure of interatrial septal communications using contemporary devices

   • Philipp Wagdi

   Original Paper Open access 30 March 2010 Pages: 507 - 510

6. Regional variation of mortality from ischemic heart disease in Germany from 1998 to 2007

   • Frank Andersohn
   • Peter Schlattmann
   • Stefan N. Willich

   Original Paper 17 April 2010 Pages: 511 - 518

   

7. Complete AV block in Lyme carditis: an important differential diagnosis

   • D. Semmler
   • R. Blank
   • H.- J. Rupprecht

   Clinical Correspondence 13 May 2010 Pages: 519 - 526

   

8. Galectin 3 in heart failure

   • Viroj Wiwanitkit

   Letter to the Editor 07 April 2010 Pages: 527 - 527

9. Prognostic value of galectin-3, a novel marker of fibrosis

   • Dirk J. Lok
   • Pieta W. Bruggink
   • Peter van der Meer

   Letter to the Editors Open access 21 May 2010 Pages: 529 - 529